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ABBREVIATIONS
EL – water extract from the external layer of C. coccineum;
PP – water extract from the  peeled C. coccineum plant; 
and WP – water extract from the whole C. coccineum plant.
INTRODUCTION
Cynomorium coccineum L. is a non-photosynthetic, para-
sitic plant of  the  Cynomoriaceae family that is  ubiquitous 
in  the  Mediterranean basin and  Arabian Peninsula [Dhar-
mananda, 2011]. It is commonly known as “tarthuth” in Arabic 
countries or Maltese “Mushroom” in the western world [Cui 
et al., 2013; Dharmananda, 2011] because it does not have any 
chlorophyll (Figure 1, part (a)). The Cynomorium genus also 
includes C. songaricum, which is found in western Asia. 
Of the two Cynomorium species, C. songaricum is the most 
well-known and has been widely studied because of tradition-
al Chinese medicine. A comprehensive ethnopharmacological 
and phytochemical review on the Cynomorium genus in China 
was recently published [Cui et al., 2013]. The pharmaceutical 
and ethnobotanical properties of Maltese Mushroom are also 
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known and were recorded centuries ago. As even reported 
in the Bible [Duke, 2008], it has been utilized in antihemor-
rhoidal, aphrodisiac, hypotensive, antiemetic, and  antitu-
mor applications and  in  the stimulation of spermatogenesis 
[Dharmananda, 2011; Wang et  al., 2010; Yang et  al., 2010; 
Yu et  al., 2010]. During famines, it was eaten by  humans, 
and  it  is  currently used in herbal infusions and other food 
preparations [Cui et al., 2013; Jin et al., 2014].
Some of the biological activities of Maltese Mushroom have 
been studied in animal and in vitro models [Jin et al., 2014; Shi 
et al., 2011] and were recently reviewed [Cui et al., 2013; Jin et al., 
2014; Meng et al., 2013]. In previous works, the lipid composi-
tion of the Maltese Mushroom fi xed oil was detailed, and its bio-
logical activity towards intestinal epithelial cells was determined 
[Rosa et al., 2012, 2015]. Moreover, aqueous and methanolic 
extracts from Maltese Mushroom stems exhibited signifi cant 
antifungal [Gonçalves et  al., 2015] and  antioxidant activities 
as demonstrated by several antioxidant assays and in vitro bio-
logical models [Zucca et al., 2013a]. In these extracts, the main 
polyphenols detected were gallic acid (3,4,5-trihydroxybenzoic 
acid, CAS 149–91–7) and cyanidin 3-O-glucoside (chrysanthe-
min or kuromanin, CAS 7084–24–4). Both of these compounds 
are well-known, promising food supplements [Jayamani & 
Shanmugam, 2014; Mulabagal et al., 2012] because the biologi-
cal  activities of the polyphenolic fractions of the plant extracts 
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to anthocyanins in the external layer, whereas the external layer and peeled plant extracts both inhibited the microbial growth of several Gram-positive 
strains. In contrast, the whole plant extract had the highest anti-tyrosinase activity and exhibited pro-erectile activity when administered subcutane-
ously. Overall, this study elucidated which parts of Maltese Mushroom are responsible for its antimicrobial, antioxidant, and anti-tyrosinase activities 
and thus which extracts have potential for use in nutraceutical formulations.
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are currently widely studied [Chahmi et al., 2015; Sanjust et al., 
2008; Traka & Mithen, 2011]. In particular, several studies fo-
cused on the composition of edible and medicinal plant extracts 
to determine their benefi cial health effects and  their potential 
use as a food supplement [Traka & Mithen, 2011; Zucca et al., 
2013a]. These reports demonstrate that Maltese Mushroom 
is a promising nutraceutical source.
Maltese Mushroom has a red-brown external layer (EL), 
whereas the peeled plant (PP) is nearly colorless (see Figure 1, 
part (b)). Gallic acid is  nearly equally distributed between 
these two parts, whereas cyanidin 3-O-glucoside is  nearly 
absent in  the PP and highly concentrated in  the EL [Zucca 
et al., 2013a], which is consistent with the intense color of an-
thocyanins.
Based on these observations, the  water extracts from 
the whole plant (WP), external layer (EL) and  peeled plant 
(PP) were studied to elucidate the roles of  the main compo-
nents. The biological activities (i.e., the cytotoxicity and anti-
microbial, antioxidant, anti-tyrosinase and pro-erectile activi-
ties) of the extracts were tested to determine the specifi c plant 
parts that give rise to them. This work could potentially help 
in the formulation of Maltese Mushroom-based nutraceuticals; 
therefore, only aqueous extracts were included in this study.
MATERIALS AND METHODS
Chemicals and instrumentation 
All reagents were of the best commercial grade available 
and were used without further purifi cation. Analytical grade 
methanol, ethyl acetate, acetonitrile and 85% w/w phosphor-
ic acid solvents were obtained from Sigma-Aldrich, Fluka 
(Milan, Italy). A cyanidin-3-O-glucoside standard was pur-
chased from Extrasynthese (Genay, France). Ultrapure water 
(18 m) was obtained with a Milli-Q Advantage A10 system 
(Millipore, Milan, Italy). Spectrophotometric measurements 
were performed using an UltroSpec 2100  pro instrument 
(Amersham Bioscience, Milan, Italy). Fatty acid methyl ester 
standards were purchased from Sigma–Aldrich (Milan, Ita-
ly). All solvents were of the highest available purity and were 
also purchased from Sigma-Aldrich. Methanolic HCl (3 N) 
was purchased from Supelco (Bellefonte, PA). The fatty acid 
methyl ester content was measured using a  Hewlett-Pack-
ard (HP) 6890  gas chromatograph (Hewlett-Packard, Palo 
Alto, USA) equipped with a fl ame ionization detector (FID) 
and a cyanopropyl methylpolysiloxane HP-23 FAME column 
(30 m x 0.32 mm x 0.25 μm) (Hewlett-Packard).
Plant materials 
Maltese Mushroom was collected in April 2014 in Portos-
cuso (southwestern Sardinia, Italy), where it is known as “cagal-
loni strantaxiu”. Stem reference materials (AR-CC-2014/4/1) 
were deposited in  the  collection of  the Department of Bio-
medical Sciences at the University of Cagliari. The  samples 
were carefully handled as described elsewhere [Zucca et al., 
2013a]. In part of the samples, red-brown external layer (EL), 
colorless peeled plant (PP) (Figure 1, part (b)) were carefully 
separated from whole plant (WP), and the three samples were 
freeze-dried using Telstar LyoQuest -55 (Milan, Italy).
Preparation of  Maltese Mushroom extracts for 
antioxidant, anti-tyrosinase, antimicrobial and 
cytotoxicity experiments
Freeze-dried Maltese Mushroom plant material was 
ground to a  powder and  extracted at room temperature. 
FIGURE 1. (a) A whole plant (WP) growing in a coastal area of Sardinia, Italy. (b) Slices of Maltese Mushroom (C. coccineum) showing the vividly 
colored external layer (EL) and the nearly colorless internal peeled part (PP). The two main constituents of the extracts were determined to be gallic 
acid (c) and cyanidin 3-O-glucoside (d); the former is nearly equally distributed between the external layer (EL) and peeled plant (PP), whereas the lat-
ter is nearly absent in the PP and highly concentrated in the EL, which is consistent with the intense color of anthocyanins.
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The  material (1  g) was soaked in  5  mL of  distilled water 
and mildly agitated for 60 min. The supernatant was collected 
after centrifugation at 8000×g for 10 min at 4°C. The pro-
cedure was repeated seven times until the  supernatant was 
colorless. The  total volume of  the  extracts was lyophilized 
and stored at 4°C.
Preparation and  purifi cation of  Maltese Mushroom 
extracts for pro-erectile activity testing
A slightly different extraction procedure was followed: 1 g 
of powdered plant material was dissolved in 10 mL of H2O. Af-
ter vortexing the mixture overnight, the resulting suspension 
was centrifuged at 8000×g for 10 min at 4°C. The superna-
tant was removed and  stored at 4°C. The  remaining pow-
der was dissolved in 10 mL of H2O. After the mixture was 
vortexed for 1 h and then centrifuged at 8000×g for 15 min 
at 4°C, the supernatant was removed, combined with the fi rst 
supernatant and stored at 4°C until use (Extract Solution 1, 
ES-1). 
ES-1 (10  mL) was passed twice through a  Sep-Pak 
C18  cartridge (Waters Corporation, Milford, MA, USA) 
that had been washed with 10 mL of methanol and 10 mL 
of H2O. Then the extract solution was collected and stored 
at 4°C until use (Extract Solution 2, ES-2). It should be not-
ed that ES-2  was completely colorless. To some extent, 
ES-2 could be similar to the PP extract. The pigmented mate-
rial adsorbed in the Sep-Pak C18 was then eluted with 10 mL 
of methanol, which was collected and evaporated under a ni-
trogen stream. The  remaining material was then dissolved 
in 5 mL of saline to give a colored solution, which was stored 
at 4°C until use (Extract Solution 3, ES-3, that to some extent 
resembles the composition of the EL extract). 
Animal experiments were performed according to 
the  guidelines of  the  European Communities Directive 
of September 22, 2010 (2010/63/EU) and Italian legislation 
(D.L. March 4, 2014, n. 26) and were approved by the Ethi-
cal Committee for Animal Experimentation of the University 
of Cagliari.
Nutritional facts label
The nutritional facts were determined according to cur-
rent legislation (Regulation EU No. 1169/2011 of the Euro-
pean Parliament and of the Council of 25 October 2011 on 
the provision of food information to consumers) at the facili-
ties of “Laboratorio Chimico Merceologico della Sardegna” 
(Cagliari, Italy).
Total phenolic, fl avonoid, and  anthocyanin content 
determination
The total soluble phenolic content was determined using 
the Folin-Ciocalteu reagent as described in a previous report 
[Zucca et al., 2013a]. Gallic acid was used as the standard 
(linearity range 0.05–0.6 mmol/L), and  the  results were ex-
pressed in gallic acid milliequivalents (mGAE).
A spectrophotometric method was used to quantify the to-
tal fl avonoid content [Zucca et al., 2010a]. Briefl y, 0.25 mL 
of  the  sample, 1.25 mL of H2O, and  0.075 mL of NaNO2 
(5% w/v) were incubated for 5 min at 25°C. Then, 0.15 mL 
of AlCl3 (10% w/v) was added to the mixture. After 6 min, 
0.5 mL of 1 mol/L NaOH and 0.275 mL of H2O were also 
added, and the absorbance was measured at 510 nm. Catechin 
was used as the standard (linearity range 0.1–0.6 mmol/L), 
and  the  results were expressed in  catechin milliequivalents 
(mCE) using a standard curve.
The total anthocyanin content was determined by a spectro-
photometric assay based on differential pH absorbance [Dela-
zar et al., 2010]. Briefl y, the absorbances at 510 nm and 700 nm 
were measured at both pH 1.0 and 4.5 using 0.2 mol/L HCl/
KCl and 1 mol/L sodium acetate buffers, respectively. The fi nal 
absorbance was calculated using Equation 1.
Afin = [(A510–A700)pH1.0–(A510–A700)pH4.5] (1)
The molar extinction coeffi cient of cyanidin 3-O-glucoside 
(29,300 M-1·cm-1) was then used in  the Lambert-Beer equa-
tion to calculate the total anthocyanin concentration (Equa-
tion 2, l = optical path).
 (2)
Antioxidant assays 
The 1,1-diphenyl-2-picrylhydrazyl (DPPH·) radical scav-
enging assay was performed according to a well-known proto-
col [Huang et al., 2005]. The results were expressed in Trolox 
milliequivalents (mTE, linearity range 5–50 μmol/L) and as 
IC50 values.
The ferric reducing antioxidant power (FRAP) assay was 
performed as previously described [Huang et al., 2005]. Tro-
lox was used for the calibration curve, and  the  results were 
expressed in  Trolox milliequivalents (mTE) and  in  mmol 
of Fe(II) per gram of dry material (mmol FeII/g).
The Trolox equivalent antioxidant capacity (TEAC) assay 
was performed using the 2,2’-azinobis(3-ethylbenzothiazoline 
6-sulfonate) (ABTS) cationic radical as previously described 
[Zucca et  al., 2013a]. The  results were expressed in  Tro-
lox milliequivalents (mTE, linearity range 0.1–0.8 mmol/L) 
and as IC50 values.
The  oxygen radical absorbance capacity-pyrogallol red 
(ORAC-PYR) assay was performed according to a  recently 
described method [Zucca et  al., 2010a]. The  results were 
expressed in  Trolox milliequivalents (mTE, linearity range 
0.1–0.8 mmol/L).
Extraction and saponifi cation of Maltese Mushroom oil
Oil was extracted from the  external layer (EL) and  in-
ternal peeled part (PP) using the procedure of Folch et  al. 
[1957] in which 12 mL of  a  2:1 (v/v) CHCl3:MeOH solu-
tion was added to the powder sample. After fi ltration, 4 mL 
of H2O was added to the mixture, which was then centrifuged 
at 900×g for 1 h to separate the CHCl3  fraction (lipophilic 
extract) from the MeOH/H2O mixture. Aliquots of the dried 
CHCl3 fractions were subjected to mild saponifi cation [Rosa 
et al., 2015]. Aliquots of the dried fatty acids were then meth-
ylated with 1 mL of methanolic HCl (3 N) [Rosa et al., 2015] 
for 30 min at room temperature. After n-hexane and H2O 
were added to the samples, they were centrifuged for 20 min 
at 900×g. The hexane phase containing the fatty acid methyl 
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esters was collected, and the solvent was subsequently evapo-
rated. Then, the residue was dissolved in n-hexane, and ali-
quots of the samples were subjected to gas chromatography 
analysis (GC). All solvent evaporation procedures were per-
formed under vacuum. 
GC analysis of the fatty acid methyl esters
The  fatty acid methyl ester content was measured using 
an HP 6890 system. Nitrogen was used as the carrier gas at 
a fl ow rate of 2 mL/min. The oven, injector, and detector tem-
peratures were set to 175°C, 250°C, and 300°C, respectively. 
The  fatty acid methyl esters were identifi ed by  comparing 
the observed retention times to those of standard compounds. 
The amounts of the individual fatty acids were calculated as 
percentages of  the  total amount of  fatty acids (g %) using 
the Hewlett-Packard A.05.02 software. 
Antimicrobial activity 
All bacterial strains used in this study belong to the Leib-
niz Institute DSMZ (German Collection of Microorganism 
and Cell Cultures). In particular, four Gram-negative and fi ve 
Gram-positive reference bacterial strains were used: Staphy-
lococcus aureus DSM 1104, methicillin-resistant Staphylococ-
cus aureus (MRSA), Staphylococcus epidermidis DSM 1798, 
Enterococcus faecalis DSM 2570, Escherichia coli DSM 1103, 
Enterobacter cloacae DSM 30054T, Pseudomonas aeruginosa 
DSM 1117, Acinetobacter baumannii DSM 30007T, and Kleb-
siella pneumoniae DSM 681.
Inoculum suspensions were prepared using the direct col-
ony suspension method according to CLSI procedures [In-
stitute, 2012]. Saline suspensions of isolated colonies, which 
were selected from an 18–24 h Luria-Bertani agar plate, were 
used to achieve a  turbidity equivalent to a  0.5  McFarland 
standard.
The antibacterial activities of the Maltese Mushroom ex-
tracts were determined using the disc diffusion method ac-
cording to CLSI procedures [Institute, 2012]. Petri plates 
were prepared with 25 mL of Mueller-Hinton agar (MHA). 
The inoculum suspensions were swabbed on the MHA plate 
surface, and 1 mg of dry extract was added to each disk sepa-
rately. A negative control was prepared by placing a specifi c 
amount of Milli-Q water on the control disk surface. Genta-
micin and oxacilline were used as positive controls.
Tyrosinase inhibition 
Tyrosinase from Agaricus bisporus was purifi ed as de-
scribed previously [Sollai et al., 2008]. Experiments were per-
formed to check for possible contaminant enzyme activities 
[Rescigno et al., 2007]. In particular, syringaldazine was used 
as the substrate [Zucca et al., 2011] to rule out laccase activ-
ity (<0.001 E.U./mL [Zucca et al., 2010b]) because contami-
nant laccases might share substrates, i.e., o-diphenols, with 
tyrosinase, leading to ambiguous results.
The  tyrosinase activity was measured by  monitoring 
the  absorbance at 625  nm (625 = 11,120  M−1·cm−1) af-
ter the  formation of  an adduct between 4-tert-butyl-1,2-
-benzoquinone (TBBQ) and  4-amino-N,N-diethylaniline 
(ADA), as previously described [Rescigno et al., 1999; Zucca 
et al., 2013b]. The assay mixture, which had a fi nal volume 
of 1 mL, contained a 50 mmol/L sodium phosphate buffer at 
pH 7.0, 5 mmol/L 4-tert-butylcatechol (TBC), 0.75 mmol/L 
ADA and 2 E.U. of  the enzyme (1  tyrosinase E.U. was de-
fi ned as the amount of enzyme capable of producing 1 μmol 
of  the  adduct between TBBQ and  ADA per minute at 
pH 7 and 25°C). The tyrosinase inhibition by the test sam-
ples was quantifi ed by the concentration necessary to achieve 
50% inhibition (IC50).
Cell line and culture conditions 
The  B16F10  mouse melanoma cell line (ICLC ATL 
99010) was purchased from the National Institute for Can-
cer Research c/o CBA (Genoa, Italy). Subcultures of the cell 
line were grown in a 75 cm2 culture fl ask in DMEM medium 
supplemented with 10% fetal bovine serum (FBS), 2 mmol/L 
L-glutamine, 1% non-essential amino acids, 1 mmol/L Na-
pyruvate, 100 U/mL penicillin and 100 μg/mL streptomycin 
at 37°C in 5% CO2.
MTT assay for cell viability 
The  cytotoxic effects of  the Maltese Mushroom water 
extracts (WP, PP, and EL) were evaluated by  conducting 
the  3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium 
bromide (MTT, CAS 298–93–1) assay, in which the  tetra-
zolium salt is  cleaved by  mitochondrial dehydrogenases 
in viable cells [Rosa et al., 2012; Schiller et al., 1992], on 
the B16F10 mouse melanoma cells. MTT is a yellow, wa-
ter-soluble tetrazolium salt. Metabolically active cells can 
convert the dye into a dark blue, water-insoluble formazan 
dye by  reductively cleaving the  tetrazolium ring. In  brief, 
3×103  cells/mL in  100  μL of  medium were seeded into 
a 96-well plate and  incubated at 37°C. After a 48 h incu-
bation period, the aqueous extracts were added to the cul-
tures in  concentrations ranging from 25  to 500  μg/mL, 
and  the  cells were incubated for an additional 24  h at 
37°C. The MTT solution (8 μL, 5 mg/mL in H2O) was then 
added to the culture, which was maintained at 37°C for 4 h. 
The cells were lysed with 100 μL of DMSO, and the color 
was measured at 570 nm with an auto microplate reader 
(Infi nite 200, Tecan, Austria). The absorbance was propor-
tional to the number of viable cells. 
In addition, melanin content in  the B16F10 cell cultures 
was determined by  a  previously described method [Soddu 
et al., 2004].
Pro-erectile activity in adult male rats 
The  effects of  the  Maltese Mushroom extracts (ES-1, 
ES-2, and ES-3) on penile erection in male rats were studied 
as described in the literature [Sanna et al., 2011, 2012]. Briefl y, 
adult male Sprague-Dawley rats (225–250 g, Harlan Nossan, 
Italy) were housed at 24°C and 60% humidity and given water 
and  standard laboratory food ad libitum. Aliquots of ES-1, 
its dilutions with saline, or ES-2 or ES-3 were administered 
subcutaneously (SC) in volumes of 0.1 mL/80 g of rat body 
weight. Rats injected with the same volume of saline were used 
as controls. After treatment, each rat was placed in a Plexiglas 
cage (30 × 30 × 30 cm) by  itself and observed for 60 min 
to count the number of penile erection episodes and monitor 
other gross behavioral changes.
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Statistical analysis 
GraFit 7 (Erithacus Software, London, UK) and  the 
R 2.5.1 software (R Foundation for Statistical Computing, 
Vienna) were used for the statistical analysis. All analyses 
were performed at least in triplicate unless otherwise stated. 
The  statistical signifi cance of  differences was evaluated 
by analysis of variance (one-way ANOVA). Statistical eval-
uation of  the  penile erection experiments was performed 
using one-way ANOVA followed by Tukey’s multicompari-
son test. For the  B16F10  cell experiments, the  statistical 
signifi cance of  differences was evaluated using one-way 
ANOVA followed by the Bonferroni post-test; the differenc-
es were considered to be  signifi cant at P<0.001, P<0.01, 
and P<0.05.
RESULTS AND DISCUSSION
Nutritional facts of Maltese Mushroom 
Previous reports ascribe several biological activities to 
Maltese Mushroom [Rosa et  al., 2012; Wang et  al., 2010; 
Zucca et al., 2013a], suggesting that its extract has a potential 
for use in nutraceutical formulations. Based on the possibil-
ity that Maltese Mushroom might be used for human nutri-
tion, the nutritional facts for the whole plant were collected. 
The results are reported in Table 1. Carbohydrates, including 
27% dietary fi bers, were the principal component (approxi-
mately 50%). A signifi cant portion of protein (approximately 
9%) was also detected, whereas only a small amount of  lip-
ids (1%) were detected. Most of the  lipids were unsaturated 
fats. Particularly, polyunsaturated fats, which are thought to 
be benefi cial for many human pathological conditions [Ron-
caglioni et al., 2013], constituted nearly 40% of the total lip-
ids. Overall, the nutritional profi le of Maltese Mushroom ap-
pears to be compatible with human consumption as described 
in traditional medicine [Cui et al., 2013; Jin et al., 2014], sup-
porting the aim of this study.
Phenolic composition and antioxidant power
Phenolic compounds are the principal plant constituent as-
sociated with antioxidant activity. Accordingly, their contents 
in the WP, EL and PP extracts were quantifi ed fi rst (Table 2). 
Based on the Folin-Ciocalteu assay results, the WP extract 
had a  phenol concentration of  approximately 3.3  mmol/L 
GAE (gallic acid equivalents) per gram of dry extract, which 
is on the same order of magnitude as that measured for other 
Cynomorium specimens [Jin et al., 2014; Rached et al., 2010; 
Wong et  al., 2006] and  for typical antioxidant plants (such 
as green tea, tomatoes, and oranges) [Cieślik et  al., 2006]. 
The phenolic compounds were unevenly distributed between 
the EL and PP; their concentrations were higher (more than 
2-fold) in the red-brown external layer. The fl avonoid distri-
bution also followed this trend, and anthocyanins were only 
detected in the EL. HPLC analysis revealed that cyanidin 3-O-
-glucoside accounted for the majority of the total anthocyan-
in content [Zucca et al., 2013a]. The UV-Vis spectra of both 
the WP and EL extracts supported this conclusion: two main 
absorption maxima were observed at 277 nm and 521 nm. 
The addition of 5% AlCl3  led to a 5 nm bathochromic shift 
in the visible band, which is consistent with the presence of or-
tho-hydroxyl groups on the  cyanidin-3-O-glycoside B-ring 
[Delazar et al., 2010].
To fully assess the activities of the extracts, the total anti-
oxidant power was determined by both the ET and HAT as-
says because only hydrogen atom transfer methods (such as 
ORAC-PYR) can evaluate the antioxidant capacity in addi-
tion to the reducing power [Zucca et al., 2010a]. The results 
are listed in Table 2. All the assays showed that the EL extract 
had a higher antioxidant power (P<0.05 for each method), in-
dicating that the antioxidant capacity is mainly due to antho-
cyanins. However, both the ET and HAT assays showed that 
the PP extract also exhibited signifi cant activity (on average, 
its antioxidant power was slightly less than half that of the EL 
extract), suggesting that the colorless component of Maltese 
Mushroom could also be used in nutraceutical formulations. 
TABLE 1. Nutritional information panel for lyophilized Maltese Mush-
room. The data are for 100 g of the dried material.
Specifi cation Value
Calories 281 kcal1176 kJ
Proteins 8.69 g
Total carbohydrate 45.5 g
sugars 29.6 g
Total fat 1.0 g
saturated fat 27.36 %
polyunsaturated fat 39.57 %
monounsaturated fat 33.07 %
Sodium 765 mg
Total dietary fi ber 27.7 g
TABLE 2. Total antioxidant capacity of the Maltese Mushroom extracts 
from the external layer (EL), peeled plant (PP) and whole plant (WP). 
(n.d.) not detectable.
Assay WP extract EL extract PP extract
ORAC-PYR (mTE/g) 6.81±0.41 8.13±0.70 2.39±0.24
DPPH (mTE/g) 1.16±0.04 1.82±0.11 0.76±0.03
DPPH· (IC50 μg/mL) 10.70±0.39 9.07±0.29 25.09±1.54
TEAC (mTE/g) 3.86±0.23 5.92±0.61 1.83±0.10
TEAC (IC50 μg/mL) 188±40 109±7 266±86
FRAP (mTE/g) 2.66±0.01 3.54±0.02 1.39±0.01
FRAP (mmol FeII/g) 3.12±0.01 4.73±0.01 2.37±0.01
Total phenolics (mGAE/g) 3.34±0.01 4.97±0.22 2.06±0.02
Total fl avonoids (mCE/g) 1.12±0.01 1.86±0.02 0.87±0.01
Total anthocyanin 
(mg cyanidin 
3-O-glucoside/g)
6.6±0.3 13.7±1.2 n.d.
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Gallic acid was found to be  one of  the main components 
of the WP by HPLC analysis and was nearly equally distrib-
uted between the EL and PP [Zucca et al., 2013a]. These re-
sults indicated that gallic acid makes a signifi cant contribu-
tion to the total antioxidant activity of the Maltese Mushroom 
extracts, which is consistent with several reports of the high 
antioxidant activity and healthy effects of gallic acid and sug-
gests that it has potential for use in clinical and industrial ap-
plications [Jayamani & Shanmugam, 2014].
Composition of the Maltese Mushroom oil extracts
Qualitative and quantitative information on the individual 
fatty acids in the Maltese Mushroom EL and PP oil extracts 
was obtained by GC analyses. The  fatty acid compositions 
of the oil extracts, expressed as % of the total fatty acids, are 
reported in Table 3. The EL oil was composed of approxi-
mately 32% saturated fatty acids (SFA, mainly palmitic acid 
16:0 and 18:0, 25 and 4%, respectively), 30% monounsatu-
rated fatty acids (MUFA, mainly oleic acid 18:1 n-9 and 20:1, 
22 and 5%, respectively), and 35% polyunsaturated fatty acids 
(PUFA, mainly composed of the essential fatty acids linoleic 
acid 18:2 n-6 and a-linolenic acid 18:3 n-3, 33 and 4%, re-
spectively). The PP oil extract had a profi le similar to that 
of the EL oil, with a higher level of PUFA (39%) and  lower 
amounts of MUFA (28%) and SFA (29%). It is interesting to 
note that both oils were characterized by a high proportion 
of PUFA. The fatty acid profi le of the Maltese Mushroom oil 
obtained in this study differed from those obtained in previous 
studies [Rosa et al., 2012, 2015], possibly because the plant 
collection, extraction procedure, and plant metabolic activity 
were performed at a different time. 
However, the striking similarities between the oil compo-
sitions of the different plant parts, PP and WP indicates that 
the whole plant could be used in nutraceutical applications.
Antibacterial activity
Antibacterial activity is a crucial feature of plant extract-
based formulations. Accordingly, the  effects of  the WP, PP 
and EL extracts on several Gram-positive and Gram-nega-
tive bacterial strains, including the clinical isolate S. aureus 
MRSA, were evaluated by the disc diffusion method. The re-
sults are summarized in Table 4.
Based on the parameters suggested by Alves and cowork-
ers [Alves et  al., 2000] (inhibition zones <9 mm, inactive; 
9–12 mm, less active; 13–18 mm, active), the inhibition zones 
(1  mg/disc) of  the  aqueous Maltese Mushroom extracts 
against the Gram-positive strains, particularly those belong-
ing to the Staphylococcus genera, were considerable. Of these 
TABLE  3. Fatty acid composition (% of  total fatty acids) determined 
by GC analysis of the lipid extracts obtained from the external layer (EL) 
and internal peeled part (PP) of Maltese Mushroom using the procedure 
of Folch et al. [1957].
Fatty acids EL extract PP extract
12:0 0.34±0.11 0.21±0.11
14:0 1.28±0.27 1.08±0.12
16:0 25.02±2.49 24.28±0.83
16:1 n-7 1.96±0.62 1.45±0.09
18:0 4.34±1.06 2.81±0.73
18:1 n-7 1.41±0.14 1.39±0.09
18:1 n-9 21.70±1.27 22.79±0.25
18:2 n-6 33.34±4.17 36.66±0.43
18:3 n-3 3.84±1.20 2.81±0.15
20:0 0.43±0.21 0.24±0.08
20:1 n-9 5.51±0.53 2.77±0.25
SFA 31.84±3.61 28.69±1.42
MUFA 30.05±1.38 28.38±0.35
PUFA 34.89±3.83 39.47±0.29
SFA, saturated fatty acids; MUFA, monounsaturated fatty acids; PUFA, 
polyunsaturated fatty acids. Mean and standard deviation of 4 samples.
TABLE 4. Antibacterial activity of the aqueous Maltese Mushroom extracts determined by the disc diffusion method (inhibition zone in mm) (1 mg/
disc). Gentamicin and oxacilline were used as the reference antibiotic controls. (–) no activity.
Bacteria WP extract EL extract PP extract Antibiotic control
Gram positive
S. aureus DSM 1104 11.3±0.6 11.0±0.1 8.3±0.6 Ox 26.0±0.2
S. epidermidis DSM 1798 12.3±0.6 12.7±0.6 10.7±0.6 Ox 23.0±0.1
E. faecalis DSM 2570 9.3±0.6 8.7±0.6 7.7±0.6 Gent 12.5±0.6
Staphylococcus MRSA 10.3±0.6 10.3±0.6 10.0±0.1 –
Gram negative
E. coli DSM 1103 – – – Gent 21.8±1.3
E. cloacae DSM 30054T – – – Gent 19.5±0.6
P. aeruginosa DSM 1117 – – – Gent 18.3±0.5
A. baumannii DSM 30007T 8.7±0.6 8.3±0.6 – Gent 16.5±1.0
K. pneumoniae DSM 681 – – – Gent 21.5±1.0
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bacterial strains, the clinical isolate MRSA S. aureus, a meth-
icillin-resistant strain, is of particular clinical interest. These 
results are consistent with previous studies that showed that 
a crude acetone–water extract of C. songaricum had a moder-
ate effect on a methicillin-resistant S. aureus strain [Jin et al., 
2014]. Several mechanisms are known explaining the  anti-
microbial activity of  anthocyanins, including interference 
with permeability of cell membranes and enzyme inhibition 
by  their oxidized compounds [Marin et al., 2015]. However 
the effect of cyanidins on MRSA is actually quite controver-
sial [Hatano et al., 2005], suggesting that the antimicrobial 
activity of Maltese Mushroom is not due to anthocyanins. 
This assumption is  corroborated by  the  fact that the  EL 
and PP extracts exhibited similar antibacterial activities for all 
the tested strains (Table 4), indicating that the antimicrobial 
activity might be due to gallic acid, which is consistent with 
previous reports [Kang et al., 2008] and well-known antimi-
crobial activity of gallates (possibly due to their prooxidant 
activity [Badhani et  al., 2015]). Accordingly, the PP or WP 
should be  preferred for microbiologically active formula-
tions. Conversely, the  extracts did not substantially inhibit 
the growth of Gram-negative strains. Only A. baumannii was 
inhibited by the WP and EL extracts, although it was not in-
hibited by the PP extract, strongly suggesting that anthocya-
nins are responsible for this specifi c biological activity.
Anti-tyrosinase activity 
Tyrosinase (or polyphenol oxidase, PPO) is a copper mo-
nooxygenase involved in melanogenesis and  food browning 
[Marongiu et al., 2007; Rescigno et al., 2011]. This enzyme 
catalyzes the hydroxylation of monophenols to o-diphenols 
and  the oxidation of o-diphenols to o-quinones in  the pres-
ence of molecular oxygen. It is desirable to inhibit this enzyme 
in  food formulations to increase the shelf life of some food 
products, especially plant-based ones.
The WP, PP and EL extracts, even dialyzed samples, did 
not exhibit monophenolase or diphenolase activity for sev-
eral well-known tyrosinase substrates [Olianas et  al., 2005; 
Zucca et al., 2013b]. This fi nding supports the hypothesis that 
the PPO in plants is associated with the chloroplasts [Mayer, 
2006]. It would be interesting to investigate whether the ap-
parent absence of PPO corresponds to the absence of an en-
coding gene or to the lack of PPO gene expression.
Both the  EL and  PP extracts inhibited tyrosinase ac-
tivity, although the  EL extract was approximately twice 
as active as the  PP extract (IC50  of  EL=30.4±1.0  μg, 
IC50 of PP=70.6±3.6  μg). It  should be noted that the WP 
extract exhibited a stronger inhibition effect than both of  its 
component extracts (IC50=15.6±0.5 μg), suggesting that sec-
ondary metabolites derived from interactions between the EL 
and PP play a crucial role in  its anti-tyrosinase activity [Jin 
et al., 2014]. This fi nding is further supported by the IC50 val-
ue determined for the  main EL component cyanidin-3-O-
-glycoside (23.6±2.4 μg), which suggests that this compound 
is only responsible for a small fraction of the global anti-ty-
rosinase activity.
Overall, the  anti-tyrosinase activity data suggest that 
the WP is a possible candidate for use in food formulations 
to prevent browning.
Cytotoxic effects of the aqueous extracts on B16F10 cells
Melanoma is the most malignant skin cancer, and its oc-
currence has remarkably increased over the past few decades. 
The B16F10 mouse melanoma cell line is highly metastatic 
and is commonly used to screen antitumor agents. The cyto-
toxicity of  the aqueous Maltese Mushroom extracts against 
the B16F10  cells were tested (MTT assay) and  compared. 
Figure  2  shows the  viability, expressed as % of  the  con-
trol, of  the  B16F10  cells after incubation in  the  presence 
of different concentrations of  the EL, PP, and WP extracts 
(25–500 μg/mL) for 24 h. This concentration range was cho-
sen based on similar experiments performed with other plant 
extracts. Treatment with a  100  μg/mL EL extract solution 
signifi cantly reduced the cell viability compared to the con-
trol, and  the viability was 49% at EL extract concentrations 
of 250 and 500 μg/mL. The cell viability decreased by 41% 
and 68% when they were treated with 250 and 500 μg/mL WP 
extract solutions, respectively. Although the PP extract was 
less effective than the EL and WP extracts, it reduced the cell 
viability by 46% at a concentration of 500 μg/mL. The poten-
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FIGURE 2. Viability (expressed as % of the control) (MTT assay) after incubating melanoma B16F10 cells with the Maltese Mushroom extracts ob-
tained from the external layer (EL), internal peeled part (PP), and whole plant (WP). ***=P<0.001; **=P<0.01; *=P<0.05 vs control; a’=P<0.001 vs 
control for both cell lines.
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tial anti-cancer properties of natural extracts obtained from 
plants/herbs used in traditional medicine have received much 
attention. Evaluating the cytotoxic activities of  the aqueous 
Maltese Mushroom extracts revealed their ability to reduce 
the viability of B16F10 cancer cells. Recently, gallic acid was 
shown to induce cellular apoptosis in B16F10 melanoma cells 
[Liu et  al., 2014], probably due to the  complex prooxidant 
action of gallate compounds [Badhani et al., 2015]. A pro-
teomic approach revealed that the gallic acid-induced cellular 
apoptosis in these cells is associated with metabolic glycoly-
sis. Therefore, the cytotoxic effect observed in this study could 
be attributed to gallic acid because it is one of the major com-
ponents in the Maltese Mushroom extracts. 
In a previous study, the fi xed oil obtained from the whole 
plant by SFE extraction also signifi cantly inhibited the growth 
of  melanoma and  colon cancer cells, thus demonstrating 
the potential of Maltese Mushroom [Rosa et al., 2015].
Interestingly, the extracts did not affect the cells’ ability to 
produce melanin.
Pro-erectile activity in adult male rats 
Many studies of C. songaricum have shown that its extracts 
affect the reproductive system; therefore, many products con-
taining these extracts have been marketed for the  treatment 
of erectile dysfunction, premature ejaculation, spermatorrhea 
and general sexual health [Cui et al., 2013]. Only a few studies 
of the effects of Maltese Mushroom on the reproductive sys-
tem have appeared in the literature. Abd El-Rahman and col-
leagues found that a plant water extract induced a signifi cant 
increase in the sperm count of rats, increased the percentage 
of  live sperm and  their motility and decreased the number 
of abnormal sperm [Abd El-Rahman et al., 1999]. 
A synergistic combination of an aqueous Withania som-
nifera extract and Maltese Mushroom extract was found to 
have a  direct spermatogenic infl uence on the  seminiferous 
tubules of immature rats, presumably by exerting a testoster-
one-like effect [Abdel-Magied et al., 2001]. 
To our knowledge, the effect of Maltese Mushroom ex-
tracts on penile erection in  laboratory animals or humans 
has not been studied. Our results show for the  fi rst time 
that aqueous Maltese Mushroom extracts of  the  whole 
plant exhibited pro-erectile activity when administered 
subcutaneously in  adult male rats (see Figure  3). Be-
cause the  pro-erectile activity persisted after the  colored 
component(s) were removed from the extract and  the col-
ored component(s) did not exhibit pro-erectile activity, 
it was concluded that the pro-erectile activity was due to one 
or more colorless, highly hydrophilic components, which 
might be  present in  both the  internal and  external parts 
of  the plant and whose structures are currently unknown. 
Indeed, the plant components that have been identifi ed (i.e., 
gallic acid, cyanidin 3-O-glucoside, fl avonoids, etc.) have 
not been reported to exhibit pro-erectile activity, although 
they exert a general protective effect on penile tissues due to 
their antioxidant activity [Cui et  al., 2013]. Approximately 
10 mg of the WP extract exhibited a pro-erectile activity sim-
ilar to that induced by 20 μg of apomorphine, a dopamine 
receptor agonist well known for its ability to induce penile 
erection in  laboratory animals and humans by acting sys-
temically [Argiolas, 2005; Sanna et al., 2011]. It is currently 
unknown whether the Maltese Mushroom extracts induced 
penile erection by acting locally (i.e., in the penile tissues), 
systemically or both. These results are consistent with a US 
patent claiming that a C. songarium L. Rupr. extract exhibits 
anti-phosphodiesterase activity, potentiating the  relaxation 
of isolated cavernous smooth muscle strips by cGMP, which 
makes the extract suitable to treat erectile dysfunction (US 
Patent Ref. No. US20030157208 A1 [Wang et al., 2003]). 
SUMMARY AND CONCLUSIONS
In  the past, medicinal properties of Maltese Mushroom 
were held in  high regard [Dharmananda, 2011]. As time 
passed, its use in traditional medicine waned except in some 
populations of the Arabian peninsula.
In this study, some healthful properties of Maltese Mush-
room were verifi ed, and  other biological activities of  this 
plant (cytotoxicity against B16F10 mouse melanoma cells 
and anti-tyrosinase, antibacterial, and pro-erectile activities) 
were described for the fi rst time. Despite being results about 
only partially differentiated plant materials, needing some 
additional in-depth analysis, the  reported data highlight 
the potential of Maltese Mushroom as a  functional food. 
Accordingly, additional studies of  toxicity in  normal cell 
lines and in vivo model will be necessary prior to human ap-
plication. In fact, therapeutic effects of plant extracts could 
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FIGURE 3. Effect of Maltese Mushroom extract solutions 1, 2 and 3 on 
penile erection in male rats. ES-1 (1:0) and its dilutions (1:5; 1:10; 1:20) 
(A), ES-2 and ES-3 (B) were administered SC in aliquots of 0.1 mL/80 g 
of rat body weight. At the doses used, no gross behavioral changes were 
observed. *P< 0.01 with respect to saline-treated rats (one-way ANOVA 
followed by Tukey’s multicomparison test). § This group was treated with 
0.05 mL of ES-2 instead of 0.1 mL/80 g rat body weight.
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be associated with the presence of substances present in low 
amount in  the  extract or synergistic performance of many 
components. 
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